Indefinite Delivery Contract 36E79725D0004
Award Date
1/27/25
Last Date to Order
1/26/26
Federal Agency
National Acquisition Center
Awardee
Xlcare Pharmaceuticals Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Department of Veterans Affairs National Acquisition Center awarded a single-award Indefinite Delivery Contract (IDC) to Xlcare Pharmaceuticals Inc., a minority-owned, small disadvantaged business and economically disadvantaged woman-owned small business. The IDC has a potential value of $18,554,214.00 and a period of performance from May 24, 2021 to May 23, 2022, with four one-year option periods.
Under this IDC, Xlcare Pharmaceuticals will supply levetiracetam tablets to the VA,...
This Indefinite Delivery Contract (IDC) was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Xlcare Pharmaceuticals Inc., a minority-owned, small disadvantaged business that is certified as an economically disadvantaged woman-owned small business.
The contract has a total ceiling value of $3,129,016.00 and a period of performance from November 16, 2020 to November 15, 2025. It is a single-award IDC that allows for the ordering of various pharmaceutical...
The Department of Veterans Affairs (VA) National Acquisition Center awarded a single-award Indefinite Delivery Contract (IDC) to Xlcare Pharmaceuticals Inc., a minority-owned, small disadvantaged business, to provide 12 line items of aripiprazole tablets. The $9,697,748.40 IDC was awarded on February 1, 2021 for a base year and four one-year option periods, with an ultimate completion date of January 31, 2026.
The contract will supply aripiprazole tablets in various package sizes to the VA,...
This indefinite delivery contract (IDC) was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Xlcare Pharmaceuticals Inc., a minority-owned, small disadvantaged business and economically disadvantaged woman-owned small business. The single-award IDC has a ceiling value of $143,284,854.50 and a period of performance from September 24, 2020 to September 23, 2025, with a one-year base period and four one-year option periods.
The contract is for the supply of...
The National Acquisition Center, a civilian agency of the U.S. federal government, has awarded a single-award Indefinite Delivery Contract (IDC) to Xlcare Pharmaceuticals Inc., a minority-owned, small disadvantaged business. The $761,850 contract is for the supply of lacosamide injections to the Department of Veterans Affairs (VA), Bureau of Prisons (BOP), and Indian Health Service (IHS) over a one-year base period with four one-year option periods.
This IDC was competitively awarded without...
The Department of Veterans Affairs National Acquisition Center awarded a single-award Indefinite Delivery Contract (IDC) to Xlcare Pharmaceuticals Inc., a minority-owned, small disadvantaged business and certified economically disadvantaged woman-owned small business, to supply pantoprazole tablets. The contract has a total potential value of $28,973,375.80 and covers an initial one-year base period from June 26, 2022 to June 25, 2023, with four one-year option periods. The pantoprazole...
The Department of Veterans Affairs (VA) National Acquisition Center awarded an Indefinite Delivery Contract (IDC) to Xlcare Pharmaceuticals Inc., a minority-owned, small disadvantaged business, to provide Oxcarbazepine pharmaceutical products. The single-award IDC has a base period of performance from October 14, 2024 to October 13, 2025, with four one-year option periods, for a total potential contract value of $11,065,099.45. The contracted items will be distributed through the VA's and...
This single-award Indefinite Delivery Contract (IDC) was awarded by the U.S. Department of Veterans Affairs (VA) National Acquisition Center to Xlcare Pharmaceuticals Inc. for the supply of Montelukast NA Tablets. The contract has a 1-year base period with four 1-year option periods, for a total potential period of performance through May 9, 2026. The contract ceiling value is $23,863,543.01.
The contract aims to provide an uninterrupted source of Montelukast NA Tablets in various package...
The Department of Veterans Affairs National Acquisition Center has awarded a single-award Indefinite Delivery Contract (IDC) to Xlcare Pharmaceuticals Inc., a minority-owned, small disadvantaged business, to supply methocarbamol tablets over a one-year base period and four one-year option periods. The contract has a total ceiling value of $11,608,273.60 and will support the VA's Consolidated Mail Outpatient Pharmacy (CMOP) program as well as the VA, Department of Defense, Bureau of Prisons,...
The Department of Veterans Affairs National Acquisition Center awarded a single-award Indefinite Delivery Contract (IDC) valued at up to $63,837,600.00 to Tolmar, Inc., a foreign-owned, self-certified small disadvantaged business, to provide Luteinizing Hormone Releasing-Hormone (LHRH) kits to the VA, Department of Defense, Bureau of Prisons, and Indian Health Service.
The contract has a one-year base period from July 21, 2021 to July 20, 2022, with four one-year option periods. The...